Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis
Open Access
- 29 February 2004
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 126 (2), 425-431
- https://doi.org/10.1053/j.gastro.2003.11.013
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatmentDiseases of the Colon & Rectum, 1995
- Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.Gut, 1994
- Identification of FAP Locus Genes from Chromosome 5q21Science, 1991
- Identification and characterization of the familial adenomatous polyposis coli geneCell, 1991
- Effects of Timing of Administration and Dose of Difluoromethylornithine on Rat Colonic CarcinogenesisJNCI Journal of the National Cancer Institute, 1989
- Ornithine decarboxylase levels in the rectal mucosa of patients with colonic neoplasiaJournal of Surgical Oncology, 1988
- Polyamine Levels and Gastrin Receptors in Colon CancersAnnals of Surgery, 1988
- Ornithine Decarboxylase as a Biologic Marker in Familial Colonic PolyposisNew England Journal of Medicine, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976